Abstract
Abstract only
- Title
- Genome-wide association study (GWAS) of pazopanib efficacy and safety in patients with ovarian cancer who have not progressed following first-line standard therapy
- Creators
- Giovanni Scambia - Agostino Gemelli University PolyclinicToby Johnson - GlaxoSmithKlineAnne Floquet - Institut BergoniéFlorian Heitz - Kliniken Essen-MitteSang-Yoon Park - Center for Gynecologic Cancer, National Cancer Center, Goyang, South KoreaMartin Buck - Sir Charles Gairdner HospitalRafael ÃÂlvarez Gallego - Centro Oncológico Integral Clara Campal, Madrid, SpainMuneaki Shimada - Tottori University HospitalIgnace Vergote - KU LeuvenElisabeth Avall-Lundqvist - Karolinska University HospitalNicoletta Colombo - European Institute of OncologyAnna Maria Mosconi - Azienda Ospedaliera di PerugiaBradley J. Monk - St. Joseph's Hospital and Medical CenterJianqing Zhu - Zhejiang Cancer HospitalLingying Wu - Chinese Academy of Medical Sciences & Peking Union Medical CollegeIonel Mitrica - GlaxoSmithKlinePingkuan Zhang - GlaxoSmithKline, Shanghai, ChinaSandy Stinnett - TriangleChun-fang Xu - GlaxoSmithKlineAndreas Du Bois - Kliniken Essen-Mitte
- Publication Details
- Journal of clinical oncology, Vol.32(15_suppl), pp.5574-5574
- Identifiers
- 991005969030702656
- Academic Unit
- Obstetrics & Gynecology
- Language
- English
- Resource Type
- Journal article